Dupilumab-induced psoriasis in the setting of pembrolizumab therapy: an analysis of cytokine expression

Int J Dermatol. 2023 Aug;62(8):e424-e426. doi: 10.1111/ijd.16538. Epub 2022 Dec 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Cytokines*
  • Humans
  • Psoriasis* / chemically induced
  • Psoriasis* / drug therapy

Substances

  • pembrolizumab
  • dupilumab
  • Cytokines
  • Antibodies, Monoclonal, Humanized